Illumina Inks NIPT Deals Covering Parts of Europe | GenomeWeb

NEW YORK (GenomeWeb) – Illumina today announced agreements with three organizations for use of its next-generation sequencing technologies to develop and run non-invasive prenatal testing in parts of Europe.

Illumina's deals are with Biomnis, which plans to make NIPT available in France; with Genoma for NIPT services in Italy; and with the Center for Human Genetics and Laboratory Diagnostics, which will offer NIPT in Germany.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.